Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors.
about
Targeting gastrointestinal stromal tumors: the role of regorafenibCCR 20th Anniversary Commentary: A Genetic Mechanism of Imatinib Resistance in Gastrointestinal Stromal Tumor-Where Are We a Decade Later?Successful establishment of patient-derived tumor xenografts from gastrointestinal stromal tumor-a single center experiencePhosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study.FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.Principles of Kinase Inhibitor Therapy for Solid Tumors.Promising novel therapeutic approaches in the management of gastrointestinal stromal tumors.Clinical Pharmacokinetics and Pharmacodynamics of Cabozantinib.Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors.A Novel Receptor Tyrosine Kinase Switch Promotes Gastrointestinal Stromal Tumor Drug Resistance.Emerging drugs for the treatment of gastrointestinal stromal tumour.New targets and therapies for gastrointestinal stromal tumors.Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor.PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors.ETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor.Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor.
P2860
Q26747162-AC3BA4CD-7629-4B9D-962A-D6379918A323Q35919932-2259F75D-7F90-4CE0-91DF-D3AA94BF1FDCQ36874692-EF815E83-AF31-4171-9087-E4C6B9303D26Q37050295-F5CE95F1-9CC6-4343-92D2-8127F15C007DQ37504931-E1C1A5B3-6044-4BA3-8B3D-B5CECEAD0F8CQ38802154-95BEE9DD-9F40-46F1-9E1E-C171833DDC52Q38823874-57149947-6778-4E30-B730-51A70F5D84A1Q38979283-E08786DA-5F22-4C2C-A651-7A801DAF49B3Q39288497-33DD8498-660D-406C-892F-0EBE640E434FQ47329842-E0259133-4B42-4FAF-A65A-D064422CA34CQ47355982-3163E347-75EA-4A0A-A347-C214601EE57CQ47432725-C1D66ABC-539A-4131-9AD3-EF95231183A8Q47679393-AAB58E9E-BF72-4F0B-A29C-97E886EAFC6FQ49150658-414591A9-7B0D-48D6-BA7F-07A79531C1E8Q49678212-BCF41F5C-3B5E-4E76-BE18-56024BAB1981Q50435067-FBF9D549-1646-4B21-84CA-7ACD6DB00BEE
P2860
Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pharmacological Inhibition of ...... strointestinal Stromal Tumors.
@en
type
label
Pharmacological Inhibition of ...... strointestinal Stromal Tumors.
@en
prefLabel
Pharmacological Inhibition of ...... strointestinal Stromal Tumors.
@en
P2093
P2860
P50
P1433
P1476
Pharmacological Inhibition of ...... astrointestinal Stromal Tumors
@en
P2093
Benjamin L Green
Cristina R Antonescu
Eric C Sorenson
Ferdinand Rossi
Jonathan B Greer
Juan A Santamaria-Barria
Megan H Crawley
Michael J Beckman
Peter Besmer
Ronald P DeMatteo
P2860
P304
P356
10.1158/0008-5472.CAN-14-2564
P407
P577
2015-04-02T00:00:00Z